{
    "2019-07-26": [
        [
            {
                "time": "",
                "original_text": "医药生物公司上半年业绩分化 关注政策影响小或优势独特的细分龙头 盈利能力下降",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩分化",
                        "政策影响",
                        "细分龙头",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}